Amylyx Pharmaceuticals, Inc.
AMLX
Classement en actions
#4349
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical... Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.
Prix de l'action
$28.83
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$3.62B
Changement (1 jour)
5.49%
Changement (1 an)
88.56%
Pays
US
Échange Amylyx Pharmaceuticals, Inc. (AMLX)
Catégorie
Healthcare
Nombre d'actions en circulation pour Amylyx Pharmaceuticals, Inc. (AMLX)
Nombre d'actions en circulation au June 2026: 111.20M
Selon les derniers rapports financiers et le cours de l'action de Amylyx Pharmaceuticals, Inc., le nombre actuel d'actions en circulation est de 111.20M. À la fin de December 2023, l'entreprise avait 67.23M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Amylyx Pharmaceuticals, Inc. (AMLX) de 2019 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 111.20M | 63.18% |
| 2024 | 68.14M | 1.35% |
| 2023 | 67.23M | 1.09% |
| 2022 | 66.51M | 14.95% |
| 2021 | 57.86M | 2.48% |
| 2020 | 56.47M | 0.00% |
| 2019 | 56.47M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 128.33% |
US
|
|
| 396.00M | 256.13% |
US
|
|
| 478.91M | 330.69% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -44.08% |
NL
|
